Advertisement
Commentary| Volume 51, ISSUE 5, P741-742, May 2019

On the origin of “indolent” and “aggressive” non-functioning pancreatic neuroendocrine tumour: genetically unrelated or close relative?

  • Sébastien Gaujoux
    Correspondence
    Corresponding author at: Hôpital Cochin, Department of Hepato-Pancreato-Biliary and Endocrine Surgery, AP-HP, Paris, 75014, France.
    Affiliations
    Hôpital Cochin, Department of Hepato-Pancreato-Biliary and Endocrine Surgery, AP-HP, Paris, France

    Université Paris Descartes, Paris, France
    Search for articles by this author
Published:February 21, 2019DOI:https://doi.org/10.1016/j.dld.2019.02.003
      In the present issue of Digestive and Liver Disease, M. Falconi’s team raises interesting questions in its article “The Size of Well Differentiated Pancreatic Neuroendocrine Tumors Correlates with Ki67 Proliferative Index and is not Associated with Age” [
      • Partelli S.
      • Muffatti F.
      • Rancoita P.
      • et al.
      The Size of Well Differentiated Pancreatic Neuroendocrine Tumors Correlates with Ki67 Proliferative Index and is not Associated with Age.
      ].
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Digestive and Liver Disease
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Partelli S.
        • Muffatti F.
        • Rancoita P.
        • et al.
        The Size of Well Differentiated Pancreatic Neuroendocrine Tumors Correlates with Ki67 Proliferative Index and is not Associated with Age.
        Dig Liver Dis. 2019; 51: 735-740
        • Gaujoux S.
        • Partelli S.
        • Maire F.
        • et al.
        Observational study of natural history of small sporadic non-functioning pancreatic neuroendocrine tumors.
        J Clin Endocrinol Metab. 2013; 98: 4784-4789
        • Triponez F.
        • Sadowski S.M.
        • Pattou F.
        • et al.
        Long-term Follow-up of MEN1 Patients Who Do Not Have Initial Surgery for Small ≤2 cm Nonfunctioning Pancreatic Neuroendocrine Tumors, an AFCE and GTE study: Association Francophone de Chirurgie Endocrinienne & Groupe d'etude des Tumeurs Endocrines.
        Ann Surg. 2018; 268: 158-164
        • Ye L.
        • Zhou X.
        • Huang F.
        • et al.
        The genetic landscape of benign thyroid nodules revealed by whole exome and transcriptome sequencing.
        Nature Communications. 2017; 8: 15533
        • Sallinen V.J.
        • Le Large T.T.Y.
        • Tieftrunk E.
        • et al.
        Prognosis of sporadic resected small (≤2 cm) nonfunctional pancreatic neuroendocrine tumors – a multi-institutional study.
        HPB (Oxford). 2018; 20: 251-259
        • Curran T.
        • Pockaj B.A.
        • Gray R.J.
        • et al.
        Importance of lymph node involvement in pancreatic neuroendocrine tumors: impact on survival and implications for surgical resection.
        J Gastrointest Surg. 2015; 19 (discussion 60): 152-160
        • Ricci C.
        • Taffurelli G.
        • Campana D.
        • et al.
        Is surgery the best treatment for sporadic small (≤2 cm) non-functioning pancreatic neuroendocrine tumours? A single centre experience.
        Pancreatology. 2017; 17: 471-477
        • Morales-Oyarvide V.
        • Mino-Kenudson M.
        • Ferrone C.R.
        • et al.
        Intraductal Papillary Mucinous Neoplasm of the Pancreas in Young Patients: Tumor Biology, Clinical Features, and Survival Outcomes.
        J Gastrointest Surg. 2018; 22: 226-234
        • Nimptsch U.
        • Krautz C.
        • Weber G.F.
        • et al.
        Nationwide In-hospital Mortality Following Pancreatic Surgery in Germany is Higher than Anticipated.
        Ann Surg. 2016; 264: 1082-1090
        • Topal B.
        • Van de Sande S.
        • Fieuws S.
        • et al.
        Effect of centralization of pancreaticoduodenectomy on nationwide hospital mortality and length of stay.
        Br J Surg. 2007; 94: 1377-1381
        • Pea A.
        • Yu J.
        • Marchionni L.
        • et al.
        Genetic Analysis of Small Well-differentiated Pancreatic Neuroendocrine Tumors Identifies Subgroups With Differing Risks of Liver Metastases.
        Ann Surg. 2018; (Oct 17 [Epub ahead of print])https://doi.org/10.1097/SLA.0000000000003022
        • Roy S.
        • LaFramboise W.A.
        • Liu T.C.
        • et al.
        Loss of chromatin-remodeling proteins and/or CDKN2A associates with metastasis of pancreatic neuroendocrine tumors and reduced patient survival times.
        Gastroenterology. 2018; 154 (e8): 2060-2063
        • Raymond E.
        • Dahan L.
        • Raoul J.L.
        • et al.
        Sunitinib malate for the treatment of pancreatic neuroendocrine tumors.
        N Engl J Med. 2011; 364: 501-513
        • Scarpa A.
        • Chang D.K.
        • Nones K.
        • et al.
        Whole-genome landscape of pancreatic neuroendocrine tumours.
        Nature. 2017; 543: 65-71

      Linked Article